NexGen knee replacement claims

The recall affects the NexGen Stemmed Option Tibial Components when paired with the Legacy Posterior Stabilised (LPS) Flex Option Femoral or the LPS Flex Gender Solutions Femoral (GSF) Option Femoral, manufactured by Zimmer Biomet. The National Joint Registry identified these devices as having an unacceptably high revision rate, and Zimmer Biomet issued an urgent medical device safety notice. All affected patients should’ve been contacted by the hospital where their procedure was performed and invited back for a review.

Symptoms can include limping, knee instability, swelling, and an inability to bear weight. Not all patients will experience problems, but if you have any of these symptoms – or have been told you may need revision surgery – it’s worth speaking to us. Even if you’ve not yet developed symptoms, it’s important to attend follow-up appointments and keep records of any changes.

The process has four main stages.

First, we carry out a free case assessment to understand your situation, listen to what you want to achieve, and confirm whether you have a valid claim.

If a claim is confirmed, we gather your medical records, operation notes and recall correspondence, and review whether the implant failure was linked to a design defect or negligent surgery.

Next, we work with independent medical experts to assess your injuries, future care needs and potential revision surgery requirements. We also collect evidence and identify who is responsible. In group action cases, parts of this work can be done collectively, making the process more efficient. We’ll apply to the court and, if needed, obtain a Group Litigation Order.

Finally, we negotiate with the defendants to reach a fair settlement. Many product liability claims settle out of court, but we prepare every case thoroughly in case litigation becomes necessary. Once a settlement or decision is reached, we arrange for compensation to be paid to you.

Group action cases of this nature can take longer than individual claims, as they involve coordinating evidence across a large number of clients and, in many cases, applying for a Group Litigation Order. We’ll keep you informed throughout the process and give you a realistic picture of timescales as your case progresses. The complexity of the case – including whether revision surgery is required and the extent of the injuries involved – will also affect the timeline.

Useful evidence includes your medical records and operation notes, any recall correspondence you’ve received from your hospital, records of symptoms you’ve experienced, and documentation of any financial losses such as time off work. We’ll gather much of this evidence on your behalf, including working with independent medical and engineering experts where needed. You don’t need to have everything ready before you contact us – just get in touch and we’ll guide you through what is required.

Yes. You don’t need to have undergone revision surgery to make a claim. If you’ve received a recalled NexGen implant and have experienced symptoms or harm as a result – even if surgery has not yet taken place – it’s still worth speaking to us about your options. We’ll assess your situation honestly and advise you on whether you have a valid claim.

In most personal injury and product liability cases, you have three years from the date you became aware of your injury or the defect to make a claim. However, time limits can vary depending on the circumstances, and it’s always best to seek advice as early as possible. Contact us for a free case assessment and we’ll advise you on the relevant time limits for your situation.

Yes. We offer a free, no-obligation case assessment so you can find out whether you have a valid claim without any financial commitment. If we take on your case, we work on a no win, no fee basis, which means there is no financial risk to you when pursuing a claim.

If you’ve received one of the affected knee implants, the hospital where you had your surgery should contact you with more information. The National Joint Registry has provided hospitals with a list of patients affected by this issue. All affected patients should receive clinical follow-up and examination as outlined in the Device Safety Information Notice (DSI/2023/003).

Most claims settle without a trial. If court action is necessary, we’ll represent you at every stage and work to minimise stress.